We recommend a 'Strong Buy' rating for Alcon with a $118 price target, citing new product launches and steady growth in ...
Analyst Jeff Johnson of Robert W. Baird maintained a Buy rating on Alcon (ALC – Research Report), retaining the price target of $110.00.
Alcon Inc (ALC) reports strong international growth and prepares for new product launches despite facing competitive pressures in the US market.
Eye-care group Alcon cut its 2024 forecasts and missed market expectations for third-quarter sales on Tuesday evening, as a soft U.S. market hit its surgical business. Alcon, whose biggest market is ...
JPMorgan analyst David Adlington lowered the firm’s price target on Alcon (ALC) to CHF 79.60 from CHF 84.30 and keeps an Overweight ...
Alcon expects 2024 sales of $9.8 billion to $9.9 billion, compared with prior guidance of $9.9 billion to $10.1 billion. It expects core earnings per share of $3 to $3.05, compared with a previous ...
Alcon, the global eyecare company with manufacturing and research facilities in Berks County, reported third quarter results ...
Alcon had asked court to force NSSF to compensate it for its equipment and machinery that the Fund has been holding since ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Meeting to be held in New York on November 20 hosted by BTIG. Published first on TheFly – the ultimate source for real-time, ...